Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,084 | -1,660 | -1,957 | -1,984 | -2,768 |
| Depreciation Amortization | 304 | 248 | 172 | 72 | 94 |
| Accounts receivable | -409 | -53 | -208 | -24 | -36 |
| Accounts payable and accrued liabilities | 5 | 459 | 286 | -76 | -466 |
| Other Working Capital | 626 | 1,189 | 558 | 493 | 147 |
| Other Operating Activity | 705 | 671 | 160 | 265 | 617 |
| Operating Cash Flow | $146 | $855 | $-990 | $-1,253 | $-2,414 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -237 | -1,150 | -91 | -28 | -374 |
| Investing Cash Flow | $-237 | $-1,150 | $-91 | $-28 | $-374 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 475 | 1,095 | 1,145 | 2,825 |
| Common Stock Issued | 51 | 0 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 3 |
| Financing Cash Flow | $51 | $475 | $1,095 | $1,145 | $2,828 |
| Beginning Cash Position | 197 | 17 | 3 | 139 | 99 |
| End Cash Position | 156 | 197 | 17 | 3 | 139 |
| Net Cash Flow | $-40 | $180 | $14 | $-136 | $40 |
| Free Cash Flow | |||||
| Operating Cash Flow | 146 | 855 | -990 | -1,253 | -2,414 |
| Capital Expenditure | -237 | -1,152 | -94 | -28 | -374 |
| Free Cash Flow | -91 | -297 | -1,083 | -1,281 | -2,787 |